Cargando…
Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management
Although opioids offer potent analgesia for severe acute and chronic noncancer pain, adverse gastrointestinal effects potentially undermine their clinical utility. In particular, between 40% and 95% of patients develop opioid-induced constipation (OIC). Therefore, there is a consensus that patients...
Autores principales: | Kumar, Lalit, Barker, Chris, Emmanuel, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027019/ https://www.ncbi.nlm.nih.gov/pubmed/24883055 http://dx.doi.org/10.1155/2014/141737 |
Ejemplares similares
-
Impact and Consequences of Opioid-Induced Constipation: A Survey of Patients
por: Varrassi, Giustino, et al.
Publicado: (2021) -
Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline
por: Müller-Lissner, Stefan, et al.
Publicado: (2017) -
Clinical utility of naloxegol in the treatment of opioid-induced constipation
por: Bruner, Heather C, et al.
Publicado: (2015) -
Opioid-induced constipation: a narrative review of therapeutic options in clinical management
por: Lang-Illievich, Kordula, et al.
Publicado: (2019) -
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
por: Deibert, Peter, et al.
Publicado: (2010)